Inventor · disambiguated record
Santosh S. Kulkarni
Also filed as: KULKARNI SANTOSH · KULKARNI SANTOSH S · KULKARNI SANTOSH SHRIPAD
47 granted patents·12 pending applications·461 citations·filing 2009–2024
98Inventor score
Top patents by PatentIndex Score
59 records- 0199US11572350B1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Feb 7, 2023·17 cites·15 claims
- 0299US11267794B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Mar 8, 2022·21 cites·16 claims
- 0399US11180465B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Nov 23, 2021·25 cites·18 claims
- 0499US11111224B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Sep 7, 2021·30 cites·10 claims
- 0599US11014898B1Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted May 25, 2021·30 cites·25 claims
- 0698US12134606B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Nov 5, 2024·5 cites·19 claims
- 0798US11891368B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Feb 6, 2024·10 cites·17 claims
- 0898US11773071B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Oct 3, 2023·14 cites·15 claims
- 0998US11708340B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 1098US11377429B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 5, 2022·13 cites·5 claims
- 1198US11306064B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Apr 19, 2022·17 cites·21 claims
- 1298US11225466B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jan 18, 2022·23 cites·20 claims
- 1398US10975045B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Apr 13, 2021·23 cites·9 claims
- 1498US10941127B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Mar 9, 2021·28 cites·14 claims
- 1597US12202809B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Jan 21, 2025·4 cites·17 claims
- 1697US11603359B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2020·Granted Mar 14, 2023·11 cites·18 claims
- 1797US10793534B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2019·Granted Oct 6, 2020·21 cites·10 claims
- 1896US12060338B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Aug 13, 2024·5 cites·15 claims
- 1996US12024495B2Benzothiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2021·Granted Jul 2, 2024·5 cites·10 claims
- 2096US11591327B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2020·Granted Feb 28, 2023·6 cites·4 claims
- 2196US11261183B2Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Mar 1, 2022·11 cites·3 claims
- 2296US11046712B2Glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Jun 29, 2021·11 cites·20 claims
- 2395US12187690B2Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Granted Jan 7, 2025·4 cites·20 claims
- 2495US10995090B2Substituted dihydrobenzofuran glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted May 4, 2021·11 cites·16 claims
- 2595US10344021B2Process for the separation of enantiomers of piperazine derivativesASCENEURON SA·Filed 2017·Granted Jul 9, 2019·15 cites·20 claims
- 2694US12365658B2Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2022·Granted Jul 22, 2025·2 cites·16 claims
- 2794US11213525B2Linear glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Jan 4, 2022·9 cites·10 claims
- 2894US10696668B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2017·Granted Jun 30, 2020·12 cites·2 claims
- 2994US10336775B2Glycosidase inhibitorsASCENEURON SA·Filed 2015·Granted Jul 2, 2019·15 cites·3 claims
- 3092US10556902B2Glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Feb 11, 2020·12 cites·12 claims
- 3191US11612599B2Glycosidase inhibitorsASCENEURON SA·Filed 2017·Granted Mar 28, 2023·6 cites·11 claims
- 3290US12157734B2Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2021·Granted Dec 3, 2024·1 cites·12 claims
- 3389US12187741B2Glycosidase inhibitorsASCENEURON SA·Filed 2021·Granted Jan 7, 2025·1 cites·1 claims
- 3488US11795165B2Tetrahydro-benzoazepine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Oct 24, 2023·5 cites·12 claims
- 3588US11731972B2Spiro compounds as glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Aug 22, 2023·5 cites·15 claims
- 3686US12016852B2Pyrrolidine glycosidase inhibitorsASCENEURON SA·Filed 2019·Granted Jun 25, 2024·4 cites·16 claims
- 3785US11919901B2Inhibitors of the menin-MLL interactionSYNDAX PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·28 claims
- 3884US2025333390A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 3983US2025100983A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4082US2025115604A1Sulfoximine glycosidase inhibitorsASCENEURON SA·Filed 2024·Application pending·0 cites
- 4181US10064861B2Macrocyclic pyridazinone derivativesMERCK PATENT GMBH·Filed 2016·Granted Sep 4, 2018·4 cites·8 claims
- 4280US9567320B2Pyridazinone-amides derivativesMERCK PATENT GMBH·Filed 2014·Granted Feb 14, 2017·4 cites·7 claims
- 4379US2025019353A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4478US12195455B2Succinate and fumarate acid addition salts of piperazine derivativesASCENEURON SA·Filed 2019·Granted Jan 14, 2025·1 cites·2 claims
- 4576US12398130B2Acid addition salts of piperazine derivativesASCENEURON SA·Filed 2022·Granted Aug 26, 2025·0 cites·6 claims
- 4674US2025326728A1Benzothiadiazepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2024·Application pending·0 cites
- 4773US8809278B2Cyclic tetrapeptidesALDRICH JANE V·Filed 2009·Granted Aug 19, 2014·7 cites·24 claims
- 4866US2024067617A1Benzothia(di)azepine compounds and their use as bile acid modulatorsALBIREO AB·Filed 2023·Application pending·0 cites
- 4958US2024083845A1Sars-cov-2 mpro inhibitor compoundsHEPTARES THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 5053US2023416202A1Small Molecule Compounds and CompositionsTELO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Santosh S. Kulkarni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →